Effects of 5-Alpha Reductase Inhibitors on Erectile Function, Sexual Desire, and Ejaculation

November 2012 in “ Expert Opinion on Drug Safety ”

Serap Gür, Philip J. Kadowitz, Wayne J.G. Hellstrom

5-alpha reductase inhibitors finasteride dutasteride benign prostatic hyperplasia androgenic alopecia erectile dysfunction sexual desire orgasmic issues ejaculatory dysfunction 5ARIs Propecia Avodart BPH AA ED

TLDR 5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The document from November 22, 2012, reviews the sexual side effects of 5-alpha reductase inhibitors (5ARIs), specifically finasteride and dutasteride, which are used to treat benign prostatic hyperplasia (BPH) and androgenic alopecia (AA). It reports that these drugs are associated with a prevalence of de novo erectile dysfunction (5-9%), reduced sexual desire, and orgasmic issues, with some studies indicating persistent sexual dysfunction after discontinuation. The document cites clinical trials and regulatory agency updates, noting that sexual dysfunction rates with finasteride range from 0.8% to 15.8%, and persistent effects can last over 6 years for some patients. Ejaculatory dysfunction is less studied. The need for future research to understand the mechanisms and develop prevention and treatment strategies is emphasized, as well as the importance of informed patient counseling regarding these potential adverse effects.

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

17 / 17 results

research An Old Problem with a New Cause: 5 Alpha Reductase Inhibitors and Persistent Sexual Dysfunction

9 citations, July 2011 in “The Journal of Sexual Medicine”

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

research The Risks and Benefits of 5α-Reductase Inhibitors for Prostate Cancer Prevention

147 citations, June 2011 in “New England journal of medicine/The New England journal of medicine”

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

research Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss

185 citations, March 2011 in “The Journal of Sexual Medicine”

Finasteride for hair loss can cause long-lasting sexual side effects like low libido and erectile dysfunction.

research Finasteride-Induced Depression: New Insights Into Possible Pathomechanisms

22 citations, December 2010 in “Journal of Cosmetic Dermatology”

Finasteride may increase depression by reducing brain cell growth.

research Anti-Nociceptive and Anti-Inflammatory Properties of 5alpha-Reductase Inhibitor Finasteride in Experimental Animals

11 citations, July 2008 in “European Journal of Drug Metabolism and Pharmacokinetics”

Finasteride helps reduce pain and inflammation in animals.

research Mechanism of Salutary Effects of Finasteride on Post-Traumatic Immune/Inflammatory Response

18 citations, November 2007 in “Annals of Surgery”

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

research Finasteride 5mg and Sexual Side Effects: How Many Are Related to a Nocebo Phenomenon?

225 citations, July 2007 in “The Journal of Sexual Medicine”

Knowing about finasteride's sexual side effects increases reported dysfunction.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations, November 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

408 citations, May 2004 in “The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism”

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

1707 citations, December 2003 in “The New England Journal of Medicine”

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

research Finasteride in the Treatment of Men with Frontal Male Pattern Hair Loss

187 citations, June 1999 in “Journal of The American Academy of Dermatology”

Finasteride effectively treats frontal hair loss with few side effects.

research Finasteride

125 citations, January 1999 in “Drugs”

Finasteride effectively treats baldness but may cause sexual side effects.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations, October 1998 in “Journal of The American Academy of Dermatology”

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment Among Men with Benign Prostatic Hyperplasia

1054 citations, February 1998 in “The New England Journal of Medicine”

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

research The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic Hyperplasia

728 citations, August 1996 in “The New England Journal of Medicine”

Terazosin and finasteride effectively treat BPH, but combining them adds no extra benefit.

research Age-Related Changes in Brain and Pituitary 5α-Reductase with Finasteride (Proscar) Treatment

26 citations, July 1995 in “Neurobiology of Aging”

Finasteride affects prostate weights and pituitary activity differently with age.

research Structure of Human Type II 5 Alpha-Reductase Gene

124 citations, September 1992 in “Endocrinology”

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Related Community Posts Join

6 / 1000+ results

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 2 months ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community A meta analysis of 18 popular hair loss treatments. An 2022 guide on efficacy. From finasteride and minoxidil to caffeine shampoo, saw palmetto and biotin. 96 Scientific References included.

in Research/Science 103 upvotes 2 years ago

Most hair loss treatments are ineffective; only finasteride, dutasteride, and minoxidil show effectiveness.

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 42 upvotes 4 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

26 upvotes 10 years ago

Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.

community Topical Finasteride Doesn't Directly Reduce 5ar Enzyme on Scalp

in Finasteride/Dutasteride 72 upvotes 1 year ago

Topical Finasteride doesn't directly reduce 5ar enzyme on scalp and has the same mechanism as oral, needing to go through the liver. Users debate the accuracy of this information and discuss various studies and experiences.

community Update: 4 Month progress on Fin/Min plus dermaroller

in Progress Pictures 559 upvotes 9 months ago

A user shared a 4-month update on their hair regrowth progress using finasteride, minoxidil, a dermaroller, ketoconazole shampoo, multivitamins, and biotin, and received positive reactions and inquiries from others. They also mentioned lifestyle changes such as quitting creatine, alcohol, and smoking, which may have contributed to their success.

Related Research

2 / 2 results

research Effects of 5-Alpha Reductase Inhibitors on Erectile Function, Sexual Desire, and Ejaculation

71 citations, November 2012 in “Expert Opinion on Drug Safety”

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients

research Adverse Side Effects of 5α-Reductase Inhibitors Therapy: Persistent Diminished Libido, Erectile Dysfunction, and Depression in a Subset of Patients

223 citations, December 2010 in “The Journal of Sexual Medicine”

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.